Ilyang Pharmaceutical Co Ltd
KRX:007570
Ilyang Pharmaceutical Co Ltd
Cash from Investing Activities
Ilyang Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
Cash from Investing Activities
-₩15.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
Yuhan Corp
KRX:000100
|
Cash from Investing Activities
-₩222.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-20%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash from Investing Activities
₩225.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash from Investing Activities
-₩183.5B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-17%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash from Investing Activities
₩10.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Cash from Investing Activities
-₩7.4B
|
CAGR 3-Years
43%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
See Also
What is Ilyang Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-15.7B
KRW
Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -15.7B KRW.
What is Ilyang Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
2%
Over the last year, the Cash from Investing Activities growth was 57%. The average annual Cash from Investing Activities growth rates for Ilyang Pharmaceutical Co Ltd have been 19% over the past three years , and 2% over the past ten years .